263 related articles for article (PubMed ID: 26903577)
1. Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.
Nyame YA; Murphy AB; Bowen DK; Jordan G; Batai K; Dixon M; Hollowell CM; Kielb S; Meeks JJ; Gann PH; Macias V; Kajdacsy-Balla A; Catalona WJ; Kittles R
J Clin Oncol; 2016 Apr; 34(12):1345-9. PubMed ID: 26903577
[TBL] [Abstract][Full Text] [Related]
2. Baseline serum 25-hydroxyvitamin d levels in men undergoing radical prostatectomy: is there an association with adverse pathologic features?
Berg WT; Shapiro EY; Rothberg MB; Bergman A; Scarberry K; Wambi C; Patel T; Badani KK
Clin Genitourin Cancer; 2014 Oct; 12(5):330-4. PubMed ID: 24680790
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency predicts prostate biopsy outcomes.
Murphy AB; Nyame Y; Martin IK; Catalona WJ; Hollowell CM; Nadler RB; Kozlowski JM; Perry KT; Kajdacsy-Balla A; Kittles R
Clin Cancer Res; 2014 May; 20(9):2289-99. PubMed ID: 24789033
[TBL] [Abstract][Full Text] [Related]
4. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
Vellekoop A; Loeb S; Folkvaljon Y; Stattin P
J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.
Cole AI; Morgan TM; Spratt DE; Palapattu GS; He C; Tomlins SA; Weizer AZ; Feng FY; Wu A; Siddiqui J; Chinnaiyan AM; Montgomery JS; Kunju LP; Miller DC; Hollenbeck BK; Wei JT; Mehra R
J Urol; 2016 Aug; 196(2):405-11. PubMed ID: 26920466
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
7. Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade, and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy.
Bhindi B; Xie WY; Kulkarni GS; Hamilton RJ; Nesbitt M; Finelli A; Zlotta AR; Evans A; van der Kwast TH; Alibhai SM; Trachtenberg J; Fleshner NE
Urology; 2016 Jul; 93():77-85. PubMed ID: 27015944
[TBL] [Abstract][Full Text] [Related]
8. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
[TBL] [Abstract][Full Text] [Related]
9. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
10. Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study.
Gilliland FD; Hoffman RM; Hamilton A; Albertsen P; Eley JW; Harlan L; Stanford JL; Hunt WC; Potosky A; Stephenson RA
J Urol; 1999 Oct; 162(4):1341-5. PubMed ID: 10492193
[TBL] [Abstract][Full Text] [Related]
11. Association among plasma 1,25(OH)
Ramakrishnan S; Steck SE; Arab L; Zhang H; Bensen JT; Fontham ETH; Johnson CS; Mohler JL; Smith GJ; Su LJ; Woloszynska A
Prostate; 2019 Jul; 79(10):1117-1124. PubMed ID: 31077420
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D concentration, established and emerging cardiovascular risk factors and risk of myocardial infarction before the age of 60 years.
Deleskog A; Piksasova O; Silveira A; Samnegård A; Tornvall P; Eriksson P; Gustafsson S; Ostenson CG; Ohrvik J; Hamsten A
Atherosclerosis; 2012 Jul; 223(1):223-9. PubMed ID: 22652526
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D insufficiency is common in patients with nonmetastatic prostate cancer.
Choo CS; Mamedov A; Chung M; Choo R; Kiss A; Danjoux C
Nutr Res; 2011 Jan; 31(1):21-6. PubMed ID: 21310302
[TBL] [Abstract][Full Text] [Related]
14. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
Grossfeld GD; Chang JJ; Broering JM; Li YP; Lubeck DP; Flanders SC; Carroll PR
J Urol; 2001 Mar; 165(3):851-6. PubMed ID: 11176485
[TBL] [Abstract][Full Text] [Related]
15. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
Makarov DV; Humphreys EB; Mangold LA; Walsh PC; Partin AW; Epstein JI; Freedland SJ
J Urol; 2006 Aug; 176(2):554-8. PubMed ID: 16813888
[TBL] [Abstract][Full Text] [Related]
16. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
17. Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States.
Weiner AB; Patel SG; Eggener SE
Urol Oncol; 2015 Apr; 33(4):164.e11-7. PubMed ID: 25624093
[TBL] [Abstract][Full Text] [Related]
18. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
19. Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?
Murphy AB; Nyame YA; Batai K; Kalu R; Khan A; Gogana P; Dixon M; Macias V; Kajdacsy-Balla A; Hollowell CM; Catalona WJ; Kittles R
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):55-60. PubMed ID: 27725729
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
